Skip to content

Drainage of Tuberculous Pleural Effusions

Drainage of Tuberculous Pleural Effusions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00524147
Enrollment
64
Registered
2007-09-03
Start date
2003-10-31
Completion date
2006-12-31
Last updated
2010-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculous Pleurisy

Keywords

loculated pleural effusion, pigtail drainage, pleural effusion, pleural thickening, tuberculosis

Brief summary

Tuberculous (TB) pleurisy can cause clinical symptoms and pleural fibrosis with resultant residual pleural thickening (RPT). Therapeutic thoracentesis or initial complete drainage in addition to anti-TB drugs have been tried to rapidly relieve dyspnea caused by effusion and to decrease the occurrence of RPT. However, contradictory results are reported without clear reasons. The researchers' hypothesis is that, in addition to anti-TB medications, early effective evacuation of inflammatory exudates with or without fibrinolytic agents may hasten resolution of pleural effusion, reduce the occurrence of RPT and finally improve long-term functional outcome in patients with TB pleurisy.

Interventions

PROCEDUREPigtail drainage

Sponsors

Taipei Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of tuberculous pleurisy

Exclusion criteria

* History of invasive procedures directed into the pleural cavity * Recent severe trauma, hemorrhage, or stroke; bleeding disorder or anticoagulant therapy * Use of streptokinase in the previous 2 years * Lack of clinical symptoms caused by effusions

Design outcomes

Primary

MeasureTime frame
Chest radiography, daily monitoring of the volume of fluid drained, the time needed for resolution of fever and dyspnea, and total amounts of fluid drained, and the length of chest drainage and hospitalizationbaseline, daily after treatment within admission

Secondary

MeasureTime frame
Chest radiography and pulmonary function testing with spirometryAt discharge and at 2, 4, 6, and 12 months

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026